From: The clinical efficacy of fluticasone propionate combined with ACEI/ARB in the treatment of immunoglobulin A nephropathy
Follow-up time (months)
Supportive care group (n = 71, g/d)
Supportive care plus fluticasone group (n = 71, g/d)
p
3
1.9 [1.5, 2.5]
1.2 [0.8, 1.7]
0.001
6
2.0 [1.1, 2.5]
1.0 [0.7, 1.4]
< 0.001
9
1.8 [0.9, 2.6]
0.9 [0.5, 1.0]
0.002